Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement
- PMID: 30519174
- PMCID: PMC6276745
- DOI: 10.1159/000494081
Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement
Abstract
Background: Involvement of the central nervous system (CNS) by mycosis fungoides (MF) is rare; however, it portends a poor prognosis. While aggressive multimodality therapy may improve outcomes, the role of radiation therapy (RT) is not well defined.
Objectives: We sought to explore the efficacy of RT in the management of CNS involvement by MF.
Method: We retrospectively identified five patients with MF and CNS involvement who received cranial or craniospinal RT at a single institution. Patient characteristics, disease features, radiographic findings, treatments delivered, and outcome data were extracted from the electronic medical record.
Results: All 5 patients had neurologic deficits at RT initiation, and 4 experienced at least a partial improvement. Of 4 patients evaluated by MRI after RT completion, 3 had complete resolution of CNS disease within the irradiated field. At the time of last follow-up, all patients had died of MF. The median time to death was 7.4 months (range 1.0-21 months) from their diagnosis with CNS involvement and 1.2 months (range 0.4-7.1 months) from the end of RT treatment.
Conclusions: We observed high rates of radiographic response and palliation of neurological symptoms. Nonetheless, all patients succumbed to their disease shortly after treatment, confirming the poor prognosis of this condition. Our findings suggest that RT may play a valuable palliative role for these patients.
Keywords: CNS, Brain; Cutaneous lymphoma; Mycosis fungoides; Sezary syndrome.
Similar articles
-
Clinical outcomes and prognostic factors in patients with mycosis fungoides who underwent radiation therapy in a single institution.Radiat Oncol J. 2018 Jun;36(2):153-162. doi: 10.3857/roj.2017.00542. Epub 2018 Jun 29. Radiat Oncol J. 2018. PMID: 29983036 Free PMC article.
-
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.Turk J Haematol. 2018 Mar 1;35(1):35-41. doi: 10.4274/tjh.2016.0502. Epub 2017 May 23. Turk J Haematol. 2018. PMID: 28533196 Free PMC article.
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. J Am Acad Dermatol. 2014. PMID: 24438970 Review.
-
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.Br J Dermatol. 2006 Oct;155(4):756-62. doi: 10.1111/j.1365-2133.2006.07428.x. Br J Dermatol. 2006. PMID: 16965425
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review.
Cited by
-
A comprehensive update of extracutaneous involvement of mycosis fungoides: A narrative review of literature.Medicine (Baltimore). 2025 May 9;104(19):e42279. doi: 10.1097/MD.0000000000042279. Medicine (Baltimore). 2025. PMID: 40355202 Free PMC article. Review.
-
Central Nervous System Manifestations of Cutaneous Lymphomas.Curr Neurol Neurosci Rep. 2025 Mar 25;25(1):27. doi: 10.1007/s11910-025-01416-8. Curr Neurol Neurosci Rep. 2025. PMID: 40131611 Review.
-
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.CNS Oncol. 2023 Dec 1;12(4):CNS105. doi: 10.2217/cns-2023-0014. Epub 2023 Oct 25. CNS Oncol. 2023. PMID: 37877303 Free PMC article. Review.
References
-
- Foss FM, Girardi M. Mycosis Fungoides and Sezary Syndrome. Hematol Oncol Clin North Am. 2017 Apr;31((2)):297–315. - PubMed
-
- Epstein EH, Jr, Levin DL, Croft JD, Jr, Lutzner MA. MYCOSIS FUNGOIDES. Mycosis Fungoides. Med. Baltim. 1972;51((1)):61–72. - PubMed
-
- Stein M, Farrar N, Jones GW, Wilson LD, Fox L, Wong RK, et al. Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors. Cancer J. 2006 Jan-Feb;12((1)):55–62. - PubMed
-
- Kaufman DK, Habermann TM, Kurtin PJ, O'Neill BP. Neurological complications of peripheral and cutaneous T-cell lymphomas. Ann Neurol. 1994 Oct;36((4)):625–9. - PubMed
-
- Hallahan D, Griem M, Griem S, Duda E, Baron J. Mycosis fungoides involving the central nervous system. J Clin Oncol. 1986 Nov;4((11)):1638–44. - PubMed
Publication types
LinkOut - more resources
Full Text Sources